Literature DB >> 12467243

Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily.

L A J O'Neill1.   

Abstract

Toll-like receptors (TLRs) are an important point of first contact between host and microbe, and once activated generate signals which culminate in the induction of genes important for host defence. TLRs respond to different microbial products, and the signalling pathways activated are very similar to that generated by the pro-inflammatory cytokine interleukin-1 (IL-1). This is because the Type I IL-1 receptor and TLRs are highly homologous in their cytosolic portions, possessing a Toll/IL-1 receptor (TIR) domain. Signals triggered include the important transcription factor NF-kappa B and two MAP kinases, p38 and Jun N-terminal kinase. Receptor-proximal proteins involved include the adapter MyD88, IRAK, IRAK-2, Tollip, TRAF6 and TAK-1. These latter two proteins need to be ubiquitinated in order to be active. Differences between signals generated by TLRs are emerging, with TLR-4 signalling requiring an additional adapter termed MyD88-adapter-like (Mal), which may regulate the expression of genes specific for the response required to eliminate infection by Gram-negative bacteria. Future studies on TLR signalling may reveal hitherto unsuspected specificities in the innate immune response to infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12467243

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  63 in total

1.  A20 and ABIN-3 possibly promote regression of trehalose 6,6'-dimycolate (TDM)-induced granuloma by interacting with an NF-kappa B signaling protein, TAK-1.

Authors:  Yusuke Sakai; Kazuyuki Uchida; Hiroyuki Nakayama
Journal:  Inflamm Res       Date:  2011-12-16       Impact factor: 4.575

Review 2.  Interactions of interleukin-1 with neurotrophic factors in the central nervous system: beneficial or detrimental?

Authors:  Wilma J Friedman
Journal:  Mol Neurobiol       Date:  2005-10       Impact factor: 5.590

3.  Rac1 GTPase regulates osteoclast differentiation through TRANCE-induced NF-kappa B activation.

Authors:  Na Kyung Lee; Han Kyung Choi; Dong-Ku Kim; Soo Young Lee
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

4.  Prototypical anti-inflammatory cytokine IL-10 prevents loss of IGF-I-induced myogenin protein expression caused by IL-1beta.

Authors:  Klemen Strle; Robert H McCusker; Rodney W Johnson; Samantha M Zunich; Robert Dantzer; Keith W Kelley
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-02-12       Impact factor: 4.310

5.  The cytosolic pattern recognition receptor NOD1 induces inflammatory interleukin-8 during Chlamydia trachomatis infection.

Authors:  Kerry R Buchholz; Richard S Stephens
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

Review 6.  Flagellin a toll-like receptor 5 agonist as an adjuvant in chicken vaccines.

Authors:  Shishir Kumar Gupta; Preety Bajwa; Rajib Deb; Madhan Mohan Chellappa; Sohini Dey
Journal:  Clin Vaccine Immunol       Date:  2014-01-22

7.  Correlation between TLR2, TLR3, TLR4, and TLR9 polymorphisms and susceptibility to and prognosis of severe hepatitis among the newborns.

Authors:  Xiao Qiu; Yubin Dong; Yaqin Cao; Yingmei Luo
Journal:  J Clin Lab Anal       Date:  2017-07-13       Impact factor: 2.352

8.  Inflammasomes are important mediators of cyclophosphamide-induced bladder inflammation.

Authors:  Francis M Hughes; Nivardo P Vivar; James G Kennis; Jeffery D Pratt-Thomas; Danielle W Lowe; Brooke E Shaner; Paul J Nietert; Laura S Spruill; J Todd Purves
Journal:  Am J Physiol Renal Physiol       Date:  2013-11-27

9.  Gangliosides trigger inflammatory responses via TLR4 in brain glia.

Authors:  Ilo Jou; Jee Hoon Lee; Soo Young Park; Hee Jung Yoon; Eun-Hye Joe; Eun Jung Park
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

10.  Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin.

Authors:  Kristiana Kandere-Grzybowska; Duraisamy Kempuraj; Jing Cao; Curtis L Cetrulo; Theoharis C Theoharides
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.